News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Unilabs SA Announces First-Year Status on CE Marked STRATIFY JCV® ELISA Testing


3/21/2012 7:27:35 AM

COPENHAGEN, Denmark--(BUSINESS WIRE)--Unilabs today announced the one-year status on testing in Europe and several other markets outside Europe with the CE marked ELISA test STRATIFY JCV®. STRATIFY JCV is an important tool used to help enable individual benefit-risk assessment for patients with multiple sclerosis (MS) by identifying their anti-JC virus (JCV) antibody status. In 2011, Unilabs was selected by Biogen Idec and Elan Corporation, plc to provide STRATIFY JCV testing services for the detection of anti-JCV antibodies.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES